This offer has been in front of the BOD for a considerable time , imo.
Furthermore, Rubric Capital, the owner of 100% of the Mayne Pharma Convertible Notes issued
31 December 2022 has agreed to divest its Convertible Notes at Completion of the Scheme to
Cosette for a value equivalent to the amount payable to Rubric had the Convertible Notes been
converted by Rubric to Mayne Pharma shares and acquired at the Scheme Consideration.
To get a Con note owner to vary the terms is hard to do and does not happen quickly.. so they have been working on this for some time.
MYX Price at posting:
$7.21 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)